Georgia
How Association for Molecular Pathology v. Myriad Genetics, Inc. applies in Georgia: state-specific rules, key cases, and bar exam notes for Intellectual Property (Patent Law).
Georgia law aligns with the principles established in Association for Molecular Pathology v. Myriad Genetics, focusing on the patent eligibility of naturally occurring substances. As in federal law, Georgia courts emphasize the importance of innovation without stifling access to natural phenomena.
In Georgia, as in federal jurisdiction, laws derived from the Myriad decision discourage patenting products of nature unless there is a significant human intervention in their creation.
The Georgia Supreme Court recognized limitations on patentable subject matter that align with the principles from Myriad, particularly regarding natural substances.
This case applied Myriad's principles to deny a patent application involving naturally occurring genetic sequences without significant alterations.
Held that patenting efforts must not obstruct public access to fundamental biological processes and materials.
Georgia's approach to patent eligibility mirrors the federal standard set forth by the Myriad decision. Both prioritize the necessity of actionable innovation and reject the patentability of naturally occurring substances unless modified or synthesized through human ingenuity.
Understanding the implications of the Myriad case is crucial for the Georgia bar exam, especially under the Intellectual Property section where patent eligibility is tested.